DMBT1 and inflammatory bowel disease: In the present study, we wished to evaluate the potential roles of the DMBT1 and SFTPD polymorphisms in the paediatric IBD cohort based on clinically relevant measures such as repeated flare-ups, the location of structural damage, number of hospitalisations, surgery, treatment, and overall patient’s medical history.